HematologyInvestigational

Thrombopoietin (TPO)

Subcutaneous injection, Intravenous

Overview

Thrombopoietin is a 332-amino acid endogenous glycoprotein hormone and the primary physiologic regulator of megakaryopoiesis and platelet production. It binds to the c-Mpl receptor on megakaryocyte progenitors and mature megakaryocytes, stimulating their proliferation, differentiation, and platelet release.

Mechanism of Action

Recombinant TPO and pegylated recombinant megakaryocyte growth and development factor (PEG-rHuMGDF) were developed but abandoned after clinical trials revealed antibody-mediated thrombocytopenia..

Research Summary & Key Findings

Early clinical trials of recombinant TPO in the 1990s showed efficacy in chemotherapy-induced thrombocytopenia, but development was halted after healthy volunteers and cancer patients developed neutralizing antibodies that cross-reacted with endogenous TPO, causing severe thrombocytopenia. This experience led to development of non-immunogenic TPO receptor agonists such as romiplostim and eltrombopag that do not share sequence homology with native TPO.

Clinical Status

Investigational

Thrombopoietin (TPO) is in the investigational stage. While preclinical and early-phase data exist, it has not received regulatory approval for clinical use in the United States.

Administration Routes

Subcutaneous injectionIntravenous

Related Peptides in Hematology

Bivalirudin (Angiomax)

FDA Approved

A synthetic 20-amino acid peptide that acts as a direct thrombin inhibitor by binding both the catalytic active site and...

View details

Romiplostim (Nplate)

FDA Approved

A thrombopoietin (TPO) receptor agonist consisting of a peptide sequence that binds the TPO receptor (c-Mpl) fused to an...

View details

Pegcetacoplan (Empaveli)

FDA Approved

A pegylated cyclic peptide that inhibits complement component C3, the central node of all three complement activation pa...

View details

Peginesatide (Omontys)

FDA Approved

Peginesatide is a synthetic pegylated peptide-based erythropoiesis-stimulating agent (ESA) consisting of two 21-amino ac...

View details

Find a Provider

Find a verified provider who offers Thrombopoietin (TPO) therapy in your area.

Browse Provider Map

Find a Pharmacy

Browse PCAB-accredited and FDA 503B-registered compounding pharmacies that supply Thrombopoietin (TPO).

Pharmacy Directory

Join the Association

Access exclusive peptide protocols, provider resources, and community support.

List Your Practice

Disclaimer: This information is provided for educational and research purposes only. It is not intended as medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before starting any peptide therapy. The Peptide Association does not endorse or recommend any specific treatment protocol.